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Abstract 
Von Willebrand factor, the largest human 
plasma protein, is an adhesive multimeric 
glycoprotein that mediates platelet adhesion to 
both the subendothelial matrix and endothelial 
surfaces and acts as a carrier for coagulation 
factor VIII in the circulation. Von Willebrand 
disease (vWD) is the most common inherited 
bleeding condition that involves extended or 
excessive bleeding and is caused by the 
deficiency or defect of vWF. In this case report, 
we present vWD diagnosed after hemorrhage 
following hysteroscopic myoma resection and 
endometrial band excision. The importance of 
a detailed medical history is emphasized as 
even health care workers cannot 
spontaneously give this information. Further 
tests are recommended in patients who have a 
history of prolonged bleeding as bleeding time 
and other routine coagulation tests done 
preoperatively cannot always make a definite 
diagnosis.  
1Department of Obstetrics and Gynecology, 
Universal Hospitals Group, Malatya, Turkey 
Introduction 
The success of a surgical intervention 
depends on the control of the infection, 
hemorrhage and pain. The diagnosis 
and treatment of an abnormal 
hemostatic condition and the 
prevention and control of 
hemorrhaging are essential for the 
success of an operation. Preoperative, 
intraoperative and postoperative 
hemorrhages are potential 
complications for each patient 
undergoing surgery.1  
Herein, we report a case whose 
medical history, physical examination 
and hemostasis tests were normal, yet 
developed postoperative hemorrhage 
and was diagnosed with von 
Willebrand’s disease (vWD).  
Case Report  
The 26 year old patient, who is a 
nurse, was admitted to the Gynecology 
and Obstetrics Clinic of Universal 
Malatya Hospital with intermenstrual 
bleeding, menorrhagia and secondary 
infertility on November 17, 2012. 
Vaginal examination revealed a normal 
vulva and vagina, and a cervical 
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erosion measuring 3x2 cm. 
Endometrial thickness was 18 mm in 
the middle parts of the endometrium 
and in the area adjacent to the cervix. 
An intramural subserous myoma 
measuring 28x26 mm was detected 
near the fundus. The patient 
underwent operative hysteroscopy 3 
days later. Hysteroscopy revealed a 
grayish-white avascular endometrial 
band connecting both lateral walls of 
the uterus (Figure 1). 
  
Figure 1: Hysteroscopy revealed a 
grayish-white avascular endometrial 
band connecting both lateral walls 
of the uterus. 
The band was excised through a 
resectoscope and it proceeded into the 
cavity. A subserous myoma originating 
from the right wall of the uterus close 
to the fundus and measuring 3x3 cm 
was detected (Figure 2).  
Hysteroscopic myoma resection was 
completed and the patient was 
discharged 4 hours after the operation. 
The patient reported vaginal 
hemorrhaging and she was re-





Figure 2 (focused submucous 
myoma): Submucous myoma 
originating from the right wall of the 
uterus close to the fundus and 
measuring 3x3 cm was detected. 
was 5.02 x 106uL, hemoglobin was 
15.5 g/dl and hematocrit was 44.1% in 
the preoperative period. Platelet count 
and coagulation tests were normal. 
The erythrocyte count was found to be 
3.94 x 106, hemoglobin was 11.9 g/dl 
and hematocrit was 34.6% following 
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the vaginal hemorrhage. A vaginal 
leakage originating from the uterus 
was detected on vaginal examination 
and diagnostic hysteroscopy (Figure 
3). The patient was found to have 
prolonged menstrual bleeding and 
wound healing. She stated that she 
had prolonged bleeding during and 
after a caesarean section and that she 
had received a blood transfusion in the 
postoperative period. vWD was 
suspected based on these findings, 
and desmopressin and antifibrinolytic 
therapy was initiated. Bleeding was 
reduced but did not cease. A diagnosis 
of vWD was made as von Willebrand’s 
factor (vWF) antigen level and 
vWFRcoF (ristocetin cofactor) activity 
was found to be 28. The patient was 
administered factor VIII (FVIII) 
concentrate containing 30 U/kg vWF 
via intravenous route and bleeding was 
then under control.  
Discussion  
A patient who is being prepared for an 
operation must be questioned in terms 
of family history of hemorrhagic 
diathesis, previous operations and 
tooth extractions, history of hematuria, 
gastrointestinal hemorrhage, easily 
developing ecchymosis with simple 
traumas, hemarthrosis, 
menometrorrhagia or epistaxis. Even 
health care workers cannot give this 
medical history despite previous 
histories, as in our case. A detailed 
history of previous operations and 
menstrual bleeding patterns could 
have led us to suspect this disease. 
Postoperative hemorrhage may be 
related to both a reduced number of 
platelets and also platelet dysfunctions. 
Congenital diseases associated with 
poor platelet functions are divided into 
four major groups according to the type 
of dysfunction; a) adhesion to collagen, 
 
Figure 3: A vaginal leakage 
originating from the uterus was 
detected on vaginal examination 
and diagnostic hysteroscopy. 
b) adhesion to subendothelium, c) 
release defects, d) ADP aggregation 
defects. All congenital defects except 
vWD in which there is a defect of 
adhesion to the subendothelial region 
are rare. vWD is an autosomal 
dominantly inherited disease 
characterized by absence, reduced 
production or abnormal functioning of a 
large multimetric protein, vWF, 
synthesized by the vascular 
endothelium and megakaryocytes. 
vWF is responsible for the regular 
binding of platelets to the collagen 
surface that emerges with a vascular 
trauma. Its absence leads to 
insufficient binding of platelets to the 
tear in the vascular bed by hindering 
platelet plug formation, which is 
essential for normal hemostasis. This 
condition cannot be detected in many 
patients until a vascular trauma 
develops or a surgical intervention is 
applied. In addition, those patients are 
partially sensitive to aspirin or other 
antiplatelet therapies, and a surgical 
intervention leads to severe bleeding in 
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those patients. vWD is the most 
common congenital coagulation 
disorder and the likelihood of being 
undetected until surgery is the highest. 
This disease is particularly dangerous 
because there is no history of surgical 
bleeding and preoperative coagulation 
tests are normal in its mild forms.1   
Prevalence of vWD is 1% and 
excessive uterine bleeding is the most 
common problem for female patients, 
usually in the form of menorrhagia.2 
vWD is detected in 10-20% of the 
patients who are admitted to 
gynecology clinics with complaints of 
menorrhagia.3,4 The history of 
menorrhagia could be alarming for the 
diagnosis of the disease and vWD 
could not be detected preoperatively 
with screening tests like bleeding time, 
coagulation time and prothrombin time, 
in our case. Classical laboratory 
findings of vWD include reduced vWF 
level, vWF ristocetin cofactor activity 
(RcoF), FVIII coagulation activity and 
reduced or increased platelet 
aggregation with ristocetin (RIPA).5 
Diagnosis was not suspected initially in 
our case; however, a diagnosis of vWD 
was suspected thereafter due to 
postoperative hemorrhage, prolonged 
bleeding and partial response to 
desmopressin and antifibrinolytic 
treatment. The disease was detected 
with further tests. Prothrombin time is 
normal in a great proportion of patients 
with type I vWD and the vast majority 
of patients with type 2A, 2B, 2M as it is 
prolonged only when FVIII-C level 
decreases below 40% of normal 
values. Therefore, tests of bleeding 
time, FVIII-C procoagulant activity, 
vWF antigen level, RcoF activity and 
ristocetin-induced platelet aggregation 
tests must be performed together in 
patients who are suspected to have 
vWD. The bleeding time test has 
previously been accepted as essential; 
however, its reliability is poor as 
bleeding time is found to be normal in 
a great proportion of type I vWD 
patients and the reproducibility of the 
test is low. The PFA-100 system which 
has been developed in recent years is 
an in vitro primary hemostasis test 
which has taken the place of the 
bleeding time test and it is emphasized 
that it may exclude diagnosis of vWD. 
Further studies are needed to take the 
place of a more specific vWF assay 
test.6  
Conclusion  
In conclusion, a good medical history 
and family history must be obtained 
from the patient in order to make an 
early diagnosis and prevent 
complications in subclinical cases of 
vWD, which is the most common 
hemorrhagic diathesis. The importance 
of a detailed medical history is 
emphasized. Further tests are 
recommended in patients who have a 
history of prolonged bleeding as 
bleeding time and other routine 
coagulation tests done preoperatively 
cannot always make a definite 
diagnosis.  
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